Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

Author information

Affiliations

  • 1. Department of Medicina, Universitat de Barcelona, Spain.
      Authors
    • Marrades RM 1
    (1 author)

ORCIDs linked to this article

The Journal of Clinical Investigation, 01 May 1996, 97(9):2092-2100
https://doi.org/10.1172/jci118646 PMID: 8621799 PMCID: PMC507284

Free full text in Europe PMC

Abstract 

Erythropoietin (rHuEPO) has proven to be effective in the treatment of anemia of chronic renal failure (CRF). Despite improving the quality of life, peak oxygen uptake after rHuEPO therapy is not improved as much as the increase in hemoglobin concentration ([Hb)] would predict. We hypothesized that this discrepancy is due to failure of O2 transport rates to rise in a manner proportional to [Hb]. To test this, eight patients with CRF undergoing regular hemodialysis were studied pre- and post-rHuEPO ([Hb] = 7.5 +/- 1.0 vs. 12.5 +/- 1.0 g x dl-1) using a standard incremental cycle exercise protocol. A group of 12 healthy sedentary subjects of similar age and anthropometric characteristics served as controls. Arterial and femoral venous blood gas data were obtained and coupled with simultaneous measurements of femoral venous blood flow (Qleg) by thermodilution to obtain O2 delivery and oxygen uptake (VO2). Despite a 68% increase in [Hb], peak VO2 increased by only 33%. This could be explained largely by reduced peak leg blood flow, limiting the gain in O2 delivery to 37%. At peak VO2, after rHuEPO, O2 supply limitation of maximal VO2 was found to occur, permitting the calculation of a value for muscle O2 conductance from capillary to mitochondria (DO2). While DO2 was slightly improved after rHuEPO, it was only 67% of that of sedentary control subjects. This kept maximal oxygen extraction at only 70%. Two important conclusions can be reached from this study. First, the increase in [Hb] produced by rHuEPO is accompanied by a significant reduction in peak blood flow to exercising muscle, which limits the gain in oxygen transport. Second, even after restoration of [Hb], O2 conductance from the muscle capillary to the mitochondria remains considerably below normal.

Free full text 

Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1996 May 1; 97(9): 2092–2100.
PMCID: PMC507284
PMID: 8621799

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

R M Marrades, J Roca, J M Campistol, O Diaz, J A Barberá, J V Torregrosa, J R Masclans, A Cobos, R Rodríguez-Roisin, and P D Wagner
Author information Copyright and License information Disclaimer

Abstract

Erythropoietin (rHuEPO) has proven to be effective in the treatment of anemia of chronic renal failure (CRF). Despite improving the quality of life, peak oxygen uptake after rHuEPO therapy is not improved as much as the increase in hemoglobin concentration ([Hb)] would predict. We hypothesized that this discrepancy is due to failure of O2 transport rates to rise in a manner proportional to [Hb]. To test this, eight patients with CRF undergoing regular hemodialysis were studied pre- and post-rHuEPO ([Hb] = 7.5 +/- 1.0 vs. 12.5 +/- 1.0 g x dl-1) using a standard incremental cycle exercise protocol. A group of 12 healthy sedentary subjects of similar age and anthropometric characteristics served as controls. Arterial and femoral venous blood gas data were obtained and coupled with simultaneous measurements of femoral venous blood flow (Qleg) by thermodilution to obtain O2 delivery and oxygen uptake (VO2). Despite a 68% increase in [Hb], peak VO2 increased by only 33%. This could be explained largely by reduced peak leg blood flow, limiting the gain in O2 delivery to 37%. At peak VO2, after rHuEPO, O2 supply limitation of maximal VO2 was found to occur, permitting the calculation of a value for muscle O2 conductance from capillary to mitochondria (DO2). While DO2 was slightly improved after rHuEPO, it was only 67% of that of sedentary control subjects. This kept maximal oxygen extraction at only 70%. Two important conclusions can be reached from this study. First, the increase in [Hb] produced by rHuEPO is accompanied by a significant reduction in peak blood flow to exercising muscle, which limits the gain in oxygen transport. Second, even after restoration of [Hb], O2 conductance from the muscle capillary to the mitochondria remains considerably below normal.

Full Text

The Full Text of this article is available as a PDF (213K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986 Nov 22;2(8517):1175–1178. [Abstract] [Google Scholar]
  • Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med. 1987 Jan 8;316(2):73–78. [Abstract] [Google Scholar]
  • Eschbach JW, Mladenovic J, Garcia JF, Wahl PW, Adamson JW. The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo. J Clin Invest. 1984 Aug;74(2):434–441. [Europe PMC free article] [Abstract] [Google Scholar]
  • Eschbach JW, Adamson JW. Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis. 1988 Mar;11(3):203–209. [Abstract] [Google Scholar]
  • Mayer G, Thum J, Graf H. Anaemia and reduced exercise capacity in patients on chronic haemodialysis. Clin Sci (Lond) 1989 Mar;76(3):265–268. [Abstract] [Google Scholar]
  • Macdougall IC, Lewis NP, Saunders MJ, Cochlin DL, Davies ME, Hutton RD, Fox KA, Coles GA, Williams JD. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet. 1990 Mar 3;335(8688):489–493. [Abstract] [Google Scholar]
  • Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis. 1990 Apr;15(4):325–332. [Abstract] [Google Scholar]
  • Satoh K, Masuda T, Ikeda Y, Kurokawa S, Kamata K, Kikawada R, Takamoto T, Marumo F. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients. Hypertension. 1990 Mar;15(3):262–266. [Abstract] [Google Scholar]
  • Metra M, Cannella G, La Canna G, Guaini T, Sandrini M, Gaggiotti M, Movilli E, Dei Cas L. Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure. Am J Cardiol. 1991 Oct 15;68(10):1060–1066. [Abstract] [Google Scholar]
  • Lundin AP, Akerman MJ, Chesler RM, Delano BG, Goldberg N, Stein RA, Friedman EA. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron. 1991;58(3):315–319. [Abstract] [Google Scholar]
  • McMahon LP, Johns JA, McKenzie A, Austin M, Fowler R, Dawborn JK. Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin. Nephrol Dial Transplant. 1992;7(12):1199–1206. [Abstract] [Google Scholar]
  • Davenport A. The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis. Am J Kidney Dis. 1993 Nov;22(5):685–690. [Abstract] [Google Scholar]
  • Painter P, Moore GE. The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients. Adv Ren Replace Ther. 1994 Apr;1(1):55–65. [Abstract] [Google Scholar]
  • Roca J, Agusti AG, Alonso A, Poole DC, Viegas C, Barbera JA, Rodriguez-Roisin R, Ferrer A, Wagner PD. Effects of training on muscle O2 transport at VO2max. J Appl Physiol (1985) 1992 Sep;73(3):1067–1076. [Abstract] [Google Scholar]
  • Wagner PD. Algebraic analysis of the determinants of VO2,max. Respir Physiol. 1993 Aug;93(2):221–237. [Abstract] [Google Scholar]
  • Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R, Casan P, Sans S. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986 May-Jun;22(3):217–224. [Abstract] [Google Scholar]
  • Agustí AG, Roca J, Barberá JA, Casademont J, Rodriguez-Roisin R, Wagner PD. Effect of sampling site on femoral venous blood gas values. J Appl Physiol (1985) 1994 Oct;77(4):2018–2022. [Abstract] [Google Scholar]
  • Wagner PD, Roca J, Hogan MC, Poole DC, Bebout DC, Haab P. Experimental support for the theory of diffusion limitation of maximum oxygen uptake. Adv Exp Med Biol. 1990;277:825–833. [Abstract] [Google Scholar]
  • Roca J, Hogan MC, Story D, Bebout DE, Haab P, Gonzalez R, Ueno O, Wagner PD. Evidence for tissue diffusion limitation of VO2max in normal humans. J Appl Physiol (1985) 1989 Jul;67(1):291–299. [Abstract] [Google Scholar]
  • Wagner PD. Diffusion and chemical reaction in pulmonary gas exchange. Physiol Rev. 1977 Apr;57(2):257–312. [Abstract] [Google Scholar]
  • Rosberg B, Wulff K. Regional blood flow in normovolaemic and hypovolaemic haemodilution. An experimental study. Br J Anaesth. 1979 May;51(5):423–430. [Abstract] [Google Scholar]
  • Fan FC, Chen RY, Schuessler GB, Chien S. Effects of hematocrit variations on regional hemodynamics and oxygen transport in the dog. Am J Physiol. 1980 Apr;238(4):H545–H522. [Abstract] [Google Scholar]
  • Moore GE, Bertocci LA, Painter PL. 31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients. J Clin Invest. 1993 Feb;91(2):420–424. [Europe PMC free article] [Abstract] [Google Scholar]
  • Keller MW, Damon DN, Duling BR. Determination of capillary tube hematocrit during arteriolar microperfusion. Am J Physiol. 1994 Jun;266(6 Pt 2):H2229–H2238. [Abstract] [Google Scholar]
  • Moore GE, Parsons DB, Stray-Gundersen J, Painter PL, Brinker KR, Mitchell JH. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis. 1993 Aug;22(2):277–287. [Abstract] [Google Scholar]
  • Piiper J, Scheid P. Model for capillary-alveolar equilibration with special reference to O2 uptake in hypoxia. Respir Physiol. 1981 Dec;46(3):193–208. [Abstract] [Google Scholar]
  • Hogan MC, Bebout DE, Wagner PD. Effect of hemoglobin concentration on maximal O2 uptake in canine gastrocnemius muscle in situ. J Appl Physiol (1985) 1991 Mar;70(3):1105–1112. [Abstract] [Google Scholar]
  • Diesel W, Emms M, Knight BK, Noakes TD, Swanepoel CR, van Zyl Smit R, Kaschula RO, Sinclair-Smith CC. Morphologic features of the myopathy associated with chronic renal failure. Am J Kidney Dis. 1993 Nov;22(5):677–684. [Abstract] [Google Scholar]
  • Bradley JR, Anderson JR, Evans DB, Cowley AJ. Impaired nutritive skeletal muscle blood flow in patients with chronic renal failure. Clin Sci (Lond) 1990 Sep;79(3):239–245. [Abstract] [Google Scholar]
  • Bebout DE, Hogan MC, Hempleman SC, Wagner PD. Effects of training and immobilization on VO2 and DO2 in dog gastrocnemius muscle in situ. J Appl Physiol (1985) 1993 Apr;74(4):1697–1703. [Abstract] [Google Scholar]
  • Wittenberg BA, Wittenberg JB. Effects of carbon monoxide on isolated heart muscle cells. Res Rep Health Eff Inst. 1993 Dec;(62):1–21. [Abstract] [Google Scholar]
Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

Full text links 

Read article at publisher's site: https://doi.org/10.1172/jci118646

Read article for free, from open access legal sources, via Unpaywall: http://www.jci.org/articles/view/118646/files/pdfUnpaywall

Citations & impact 

Impact metrics

59
Citations
Jump to Citations

Citations of article over time

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1172/jci118646

Supporting
Mentioning
Contrasting
5
79
0

Article citations

Go to all (59) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

NHLBI NIH HHS (1)